|
Original-Research: Rubean AG - from NuWays AG
Classification of NuWays AG to Rubean AG
Q3 figures in line with estimates // Roll-out in full swing Topic: Rubean published an interim statement with details on sales and personnel expenses that both developed as expected. In detail: 9M sales grew by 117% yoy to € 1.3m, in line with our estimates of € 1.4m, mainly driven by the further roll-out of SoftPOS that continues to materialize. Especially the cooperation with Europeans largest shoe reseller Deichmann contributed strongly to the Q3 results. EBITDA should have improved to € -1.9m (eNuW) thanks to increased sales strict, cost discipline, i.e. visible in reduced 9M personnel expenses of € 2.1m (-6% yoy). Material expenses as well as other operating expenses should have remained stable yoy (eNuW). Overall, Rubean is seen well on track: With >50k terminals live in Germany and Spain, Rubean is the market leader in both countries. In those countries, but also abroad, Rubean is now serving 1) logistic companies (CoD - Cash on Delivery) such as Correos, GLS, dpd and SEUR, 2) retailers such as REWE, Deichmann and snabble, 3) hospitality companies such as CTS eventim, Gewinnblick, Ordermann and Waldbühne Berlin as well as 4) banks and acquirers such as Sparkasse, BBVA, Global Payments and emerchantpay. As recent customer wins (i.e. Deichmann) just start to materialize, we expect a strong sales ramp-up going forward, even without new customer wins that we consider as very likely. Planned sales of c. € 1m in Q4 are in reach, in our view. With that Rubean would reach its sales guidance of € 2.2-2.5m (135% yoy at midpoint) in line with our estimates. Strong Pipeline of more well-known potential customers. As Rubean is currently in negotiations with potential customers in dozens of countries not only in Europe, but also in LATAM & US, we expect further major customer wins within the next weeks and months, additionally carrying sales growth beyond 2024. In light of the rapidly growing market for mobile payment acceptance systems we further expect Rubean to achieve profitability within FY25 and consider management’s mid-term vision of € 10+m in sales and 40+% EBIT-margin by FY27 as reasonable. BUY with a unchanged PT of € 8.50, based on our DCF. You can download the research here: http://www.more-ir.de/d/31209.pdf For additional information visit our website: www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2024415 07.11.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
